share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  May 29 10:08
Summary by Moomoo AI
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 05/29/2024, as announced by the company. The shares, valued at an aggregate market value of $1,015,876.80, were acquired by Bozic on 02/10/2024 through restricted stock vesting, a form of compensation from the issuer. This transaction follows a period where no securities were sold by Bozic in the past three months, as per the provided transaction history.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 05/29/2024, as announced by the company. The shares, valued at an aggregate market value of $1,015,876.80, were acquired by Bozic on 02/10/2024 through restricted stock vesting, a form of compensation from the issuer. This transaction follows a period where no securities were sold by Bozic in the past three months, as per the provided transaction history.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more